Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia

NCT00148616 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Chronic Schizophrenia

Interventions

DRUG: Memantine
DRUG: Placebos

Sponsor

M. Schaefer, MD

Collaborators

[object Object]